HOBBS EAMONN P
Insider CIK 1235670 · AIS President and CEO, Director · OSUR Director, Director · DCTH President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2022-05-16 | 2022-05-18 | 20,000 | $5.25 | $105.0K | 61,452 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2022-05-16 | 2022-05-18 | 2,409 | $5.25 | $12.6K | 41,452 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2021-05-18 | 2021-05-20 | 10,952 | $9.59 | $105.0K | 43,861 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2021-05-17 | 2021-05-20 | 1,446 | $9.50 | $13.7K | 32,909 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2020-05-18 | 2020-05-19 | 6,577 | $15.97 | $105.0K | 34,355 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2020-05-15 | 2020-05-19 | 2,724 | $16.04 | $43.7K | 27,778 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2019-05-21 | 2019-05-22 | 12,382 | $8.48 | $105.0K | 30,502 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2019-05-06 | 2019-05-07 | 1,351 | $9.88 | $13.3K | 18,120 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2018-05-28 | 2015-06-01 | 245,532 | — | $0 | 445,254 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2018-05-28 | 2015-06-29 | 245,532 | — | $0 | 445,254 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2018-05-14 | 2018-05-15 | 1,384 | $15.98 | $22.1K | 19,471 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2018-05-08 | 2018-05-10 | 6,144 | — | $0 | 20,855 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2017-05-16 | 2017-05-17 | 6,295 | — | $0 | 14,711 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2017-05-15 | 2017-05-17 | 3,284 | $15.13 | $49.7K | 8,416 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2016-05-17 | 2016-05-18 | 11,700 | — | $0 | 11,700 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award deriv | 2016-03-22 | 2016-03-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2015-06-22 | 2015-07-22 | 9,264 | $2.41 | $22.3K | 435,990 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 498,310 | — | $0 | 498,310 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-29 | 293,670 | — | $0 | 293,670 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-03-10 | 2015-03-12 | 92,500 | — | $0 | 92,500 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2014-09-10 | 2014-09-12 | 9,000 | $2.20 | $19.8K | 382,446 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-06-23 | 2014-06-25 | 159,498 | — | $0 | 691,930 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-06-23 | 2014-06-25 | 340,502 | — | $0 | 532,432 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-06-23 | 2014-06-25 | 182,724 | — | $0 | 282,084 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-06-23 | 2014-06-25 | 91,362 | — | $0 | 373,446 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 61,930 | — | $0 | 191,930 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-06-25 | 2013-06-27 | 23,500 | $4.19 | $98.5K | 99,360 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 27,778 | — | $0 | 122,860 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | A Award deriv | 2013-03-11 | 2013-03-13 | 135,000 | — | $0 | 135,000 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | P Buy | 2012-06-01 | 2012-06-04 | 7,000 | $1.52 | $10.6K | 162,000 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award | 2012-05-17 | 2012-05-21 | 47,070 | — | $0 | 95,082 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | A Award deriv | 2012-03-01 | 2012-03-02 | 135,000 | — | $0 | 135,000 | SEC↗ |
| DCTH DELCATH SYSTEMS INC | A Award | 2012-03-01 | 2012-03-02 | 30,000 | — | $0 | 155,000 | SEC↗ |